Predicting relapse in patients with inflammatory bowel disease: what is the role of biomarkers?
Pardi
D S
DS
Inflammatory Bowel Disease Clinic, Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. pardi.darrell@mayo.edu
Sandborn
W J
WJ
D015415:Biomarkers / Q000032:analysis; D005243:Feces / Q000737:chemistry; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis*; D039841:Leukocyte L1 Antigen Complex / Q000032:analysis*; D011379:Prognosis; D012008:Recurrence; D012680:Sensitivity and Specificity
D015415:Biomarkers; D039841:Leukocyte L1 Antigen Complex